Urogenital Abnormalities: Clinical Trials

2 trials for Urogenital Abnormalities, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2
Phase 22Active not recruiting 2

Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Part A: RM-718 or placebo (matched to specific RM-718 dose cohort), Part B: RM-718 or placebo (matched to specific RM-718 dose cohort), Part C: RM-718 - Hypothalamic Obesity, Prader-Willi Syndrome
Phase 1 / Phase 2Active not recruitingRhythm Pharmaceuticals, Inc.1112024-03-052026-10-09
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
AAV BBP-631 - Congenital Adrenal Hyperplasia
Phase 1 / Phase 2Active not recruitingAdrenas Therapeutics Inc82021-07-012025-12-23

Narrower conditions

Adrenal Hyperplasia, Congenital (1)  ·  Obesity (1)  ·  Prader-Willi Syndrome (1)  ·  Sexual Infantilism (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disorders of Sex Development (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)  ·  Gonadal Disorders (2)  ·  Male Urogenital Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Urogenital Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenogenital Syndrome (1)

Sponsors

Adrenas Therapeutics Inc (1)  ·  Rhythm Pharmaceuticals, Inc. (1)

Countries

United States (2)

Top investigators

David Meeker (1)